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INTRODUCTION:  Malignant  epithelioid  hemangioendothelioma  (EHE)  is an  uncommon  and grave  vascular
tumor.  EHE  is frequently  angiocentric  and  is  associated  with  a medium  sized  vessel,  especially  a vein.  No
deﬁnite  etiological  associations  have  been  ascribed  to this  tumor  so  far,  except  an  association  with  oral
contraceptives  in  EHE  of  liver.
PRESENTATION OF  CASE:  A 47 year  old man  presented  with  the  complaint  of intermittent  black  stool
over  the  past  two weeks.  Occasionally,  he experienced  pain  in left  lower  abdomen.  On  Computed  Tomo-
graphy  (CT),  it showed  hypervascular  lesion  in  the  ileum  with  persistent  enhancement.  An  exploratory
laparotomy  was  performed  with  short  segmental  resection  and  functional  end-to-end  anastomosis.  It
was  diagnosed  ﬁnally  with  the  histopathological  and  immunohistochemical  analysis  as a malignant  EHE.
DISCUSSION:  EHE  is  an uncommon  endothelial  tumor  that  most  frequently  arises  in  soft  tissue,  liver,  lungrognosis and  skeleton.  It behaves  biologically  in  between  benign  epithelioid  hemangioma  and  the more  aggressive
epithelioid  angiosarcoma.  Although  a  standard  systemic  treatment  for malignant  EHE  has  not  been  fully
established,  complete  surgical  excision  is  strongly  recommended  if feasible.
CONCLUSION: EHE  has  a  variable  presentation  and  CT is helpful  in  identifying  ileal  EHE timely  in the  early
stage,  even  when  there  is no obvious  mass  formation,  however  the  diagnosis  can  be  conﬁrmed  only  after
histopathological  and  immunohistochemical  studies.
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. Introduction
Epithelioid hemangioendothelioma (EHE) is an uncommon
alignant vascular tumor and characterized by an often unpre-
ictable clinical course. This disease entity was ﬁrst described by
nzinger and Weiss in 1982.1 There is no deﬁnitive association of
his disease with any causative factor except for oral contracep-
ives in hepatic EHE.2 The incidence of this tumor is less than 3%
f all tumors in the small intestine.3 Due to its variable clinical
ourse, it has been difﬁcult to identify and diagnose this disease in
he early phase. Computed tomography (CT) scan has shown some
Open access under CC BY-NC-romising investigation in identifying this disease, as described
n our case. However, ﬁnal diagnosis can be made only by the
id of histopathological and immunohistochemical studies. Due to
∗ Corresponding author at: Department of Radiology, The First Hospital of Jilin
niversity,  No. 71 XinMin Street, Changchun 130021, PR China.
el.:  +86 043188782911; fax: +86 043185654528.
E-mail addresses: 360303992@qq.com (H. Li),
eepa0205@gmail.com (D. Shah), shahabhi64@gmail.com (A. Shah),
x3290@sina.com (X. Qiu), dianbocao@gmail.com (D. Cao).
210-2612 © 2013 The Authors. Published by Elsevier Ltd on behalf of Surgical Associate
ttp://dx.doi.org/10.1016/j.ijscr.2013.09.019ed by Elsevier Ltd on behalf of Surgical Associates Ltd. 
inability to diagnose this disease in the early stage, it can lead to
high mortality and the 5-year survival rate for those patients suf-
fering from EHE is 33.5%.4 Here, we report such a patient in the
early stage when searching for the etiology of gastrointestinal tract
bleeding by multiphase CT examination. To our knowledge, no sim-
ilar case has been described in the literature yet.
2. Presentation of case
A  47-year-old man  was  admitted to our hospital with intermit-
tent black stool over the past 2 weeks. Occasionally, he experienced
intermittent pain in the left lower abdomen. On admission, phys-
ical examination was negative for abdominal palpable mass. The
patient denied taking any non-steroidal anti-inﬂammatory drugs.
Except for the positive fecal occult blood test and microcytic,
hypochromic anemia with decrease hemoglobin values down to
5.5 g/L, all the other laboratory values including tumor markers
were in the normal range. An upper gastrointestinal endoscopy
and colonic endoscopy did not reveal any cause or site of gastroin-
testinal tract bleeding. Abdominal ultrasound was also normal.
Abdominal contrast-enhanced CT scan showed a hypervascular
ense.lesion with persistent enhancement and contrast extravasations
in the ileum (Figs. 1–3). An exploratory laparotomy was immedi-
ately performed. During operation, regional bowel wall thickening
associated with a small area of ulceration was found in the ileum
s Ltd. Open access under CC BY-NC-ND license.
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Fig. 1. Axial section of CT abdomen (arterial phase) showing hypervascular lesion
in Ileum.
Fig. 2. Axial section of CT abdomen (portal phase) showing hypervascular lesion in
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Fig. 3. Coronal section of CT abdomen showing hypervascular lesion in ileum.
Fig. 4. Resected specimen showed to be malignant hemangioendothelioma on the
basis of microscopic ﬁndings.leum.
bout 150 cm proximal to the ileocecal valve, and a short segmental
esection was done with a functional end-to-end anastomosis. On
istopathological examination, resected specimen was conﬁrmed
o be malignant hemangioendothelioma with regional lymphnode
etastasis (Figs. 4 and 5). The patient had uneventful recovery
nd was discharged on 7th post-operative day. He refused for
hemotherapy or antiangiogenic agents, and died on the post-
perative follow-up of 18 months.
. Discussion
EHE is an uncommon endothelial tumor that most frequently
rises in soft tissue, liver, lung and skeleton. It behaves biolog-
cally in between benign epithelioid hemangioma and the more
ggressive epithelioid angiosarcoma. Malignant EHE can be seen
n most age groups and has its peak frequency in the 2nd and 3rd
ecades. The tumor affects males and females equally and devel-
ps in whites disproportionately more often than members of other
aces.1 Although EHE has an equal sex distribution, involvement of
he lung and liver is more frequently observed in women. There
re no good modalities for diagnosing this disease prior to surgery
Fig. 5. Resected specimen showed to be malignant hemangioendothelioma on the
basis of immunohistological stains of CD31.
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ue to its uncertain presentations. But radiological diagnosis
an sometimes be helpful, especially contrast-enhanced CT scan
n the basis of its speciﬁc constituent components, even if there
s no obvious mass formation. EHE is frequently angiocentric and
s associated with a medium sized vessel, especially a vein. The
umor, ﬁrst described in the lung was designated “intravascular
ronchioalveolar” tumor and considered to be of epithelial ori-
in. No deﬁnite etiological association has been ascribed to this
umor till now, except an association with oral contraceptives in
HE of liver. Injury and radiation therapy has also shown virtual
ssociation in the development of this tumor according to few
iteratures.2,5
EHE is pale tan in color, and lacks the red, hemorrhagic appear-
nce of conventional hemangiomas. Microscopically, it is poorly
eﬁned as an inﬁltrative tumor, characterized by nests and cords
f spindle to epithelioid cells embedded in a hyaline, myxoid, chon-
roid or collagenous stroma. The diagnostic features are the cells
hat show prominent cytoplasmic vacuoles. Red blood cells may
e present within some of these vacuoles (reminiscent of primi-
ive vascular channels). These vacuoles are mucin negative. There
s low mitotic activity and mild to moderate pleomorphism. The
umor cells express the full spectrum of immunohistochemical
ndothelial  markers including Factor VIII, CD34 and CD31 and, like
pithelioid endothelial cells in general, may  also exhibit intense
nd extensive positive staining for keratin and epithelial membrane
ntigen. The tumor cells usually do not stain with antibodies to S-
00 protein, and desmin.1,6 Differential diagnoses should be kept
n mind during establishing the diagnosis which includes other
pithelioid vascular neoplasms, particularly epithelioid heman-
ioma and angiosarcoma.
Although  a standard systemic treatment for malignant EHE has
ot been fully established, complete surgical excision is strongly
ecommended if feasible. Multifocal lesions may  be difﬁcult to
xcise and may  require radiation, chemotherapy or thermal abla-
ion. The results of a small number of single case report of EHE
atients treated with cytotoxic chemotherapy, such as doxoru-
icin or liposomal formulation, have been far from ideal.7 As new
nticancer agents, antiangiogenic agents and an inhibitor of the
yrosine-kinase, such as bevacizumab, lenalidomide, thalidomide
nd sorafenib, provide encouraging evidence of the potential ben-
ﬁt in the treatment of those patients with EHE. EHE has an
verall mortality rate of about 13%, but this can be as high as
5% for the patients whose tumor arises in liver.8 The 5-year
urvival rate for the patient with EHE is only 33.5%,4 mainly
ecause the condition is often diagnosed late. If our patient
ould have received chemotherapy or antiangiogenic agents like
orafenib, the patient could have probably lived more than 18
onths.
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4. Conclusion
It is convincing that EHE carries a grave prognosis due to lack
of diagnosis in the early stage however contrast-enhanced CT is
helpful in identifying ileal EHE timely in the early stage, even when
there is no obvious mass formation. The optimal treatment for this
disease is surgical excision if feasible. Surgical excision in combi-
nation with antiangiogenic agents is probably a promising therapy
in the future.
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